Noticias de ORCL_US

Mercado

Noticias del mercado

Últimas noticias sobre ORCL_US — 886 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: ORCL_US ✕ 886 resultados
20/10/2026 ORCL_US — ad-hoc-news.de
Mizuho keeps USD 320 target. Oracle stock loses 1.50 percent.

Fiscal first-quarter revenue hit USD 19.345 billion, up 29.6 percent. Oracle stock costs EUR 114.44

20/10/2026 ORCL_US — Stock Titan
AI may help doctors identify trial candidates sooner. Oracle and AstraZeneca will explore how.

Under a non-binding agreement, companies plan shared governance and agreed measures; possible areas include oncology, cardiovascular and rare diseases.

20/10/2026 ORCL_US — Oracle
Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

The collaboration is expected to combine AstraZeneca’s scientific and therapeutic expertise with Oracle’s health data infrastructure, cloud, AI, analytics, and clinical workflow capabilities.

19/10/2026 ORCL_US — Yahoo Finance
Oracle’s (ORCL) Growing but Can It Pay for the Buildout?

Yahoo Finance reported earlier this month, citing the Wall Street Journal, that Oracle (NYSE:ORCL) is in talks with Apollo and Goldman Sachs about paying for AI chips. Outside investors would fund a separate company that buys the chips and leases them to Oracle, so Oracle would not borrow directly. It is a lot of financial […]

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants its CEO 446,197 stock units, with vesting subject to continued employment.

The October 15 award vests 40% in 2027, 30% in 2028, 20% in 2029 and 5% each in 2030 and 2031, subject to continued employment on each vesting date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants its chief accounting officer 66,930 stock units, each tied to one share.

Vesting is 25% on October 15, 2027, then 6.25% of the original award every third month, subject to continued employment through each vesting date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) CFO's 89,240-unit stock award begins vesting at 25% on October 15, 2027.

Continued employment is required at each vesting date; 6.25% of the original award vests every third month after the initial October 15, 2027 vesting.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) awards its CEO 446,197 stock units, with vesting subject to continued employment.

The first 40% vests October 15, 2027, followed by 30% in 2028 and 20% in 2029; all installments require continued employment through vesting.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants its chief legal officer 104,113 stock units; 25% vest in 2027 if he stays.

Granted October 15, 2026, the award vests 6.25% every third month after October 15, 2027, subject to continued employment on each vesting date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants Mark Hura 237,972 stock units, with vesting tied to continued employment.

The award vests 25% on October 15, 2027, then 6.25% of the original units every three months, subject to continued employment at each vesting date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants Vice Chairman Henley 66,930 stock units tied to continued employment.

An initial 25% vests October 15, 2027, followed by 6.25% of the original grant every third month, subject to continued employment at each vesting date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) grants Ellison 223,099 stock units, with vesting subject to continued employment.

The executive chairman's award vests 40% on October 15, 2027, and 30% on October 15, 2028, subject to continued employment at each date.

19/10/2026 ORCL_US — Stock Titan
Oracle (ORCL) CEO gets 66,930 stock units, with vesting tied to continued employment.

The award vests 25% on October 15, 2027, then 6.25% of the original grant every third month, subject to continued employment on each vesting date.

Página 2 de 45